Calcium polycarbophil-alginate controlled release composition and method
AssigneeOramed Ltd.
InventorRamesh N. Acharya
Life of this patent
Estimating the term…
Loading patent…
AssigneeOramed Ltd.
InventorRamesh N. Acharya
Estimating the term…
A polymeric complex composition comprising a reaction complex formed by the interaction of a polycarbophil component with alginic acid or a salt thereof, said interaction being performed in the presence of a divalent cation and in the presence of an active agent selected from the group consisting of medicinal agents and cosmetic agents. There is also described a method of controlled release treatment comprising the steps of providing such a polymeric complex and an effective amount of an active agent selected from the group consisting of medicinal agents and cosmetic agents contained within said complex, and contacting an area of skin or mucous membrane to be treated with said composition for a sufficient period of time allow a therapeutically effective amount of said active agent to be released from the complex.
A polymeric complex composition comprising a reaction complex formed by the interaction of (1) about 0.1% to about 90% calcium polycarbophil component which is a water-swellable, but water-insoluble, fibrous, cross-linked carboxy-functional polymer, said polymer containing (a) a plurality of repeating units of which at least about 80 percent contain at least one carboxyl functionality, and (b) about 0.05 to about 1.5 percent cross-linking agent substantially free from polyalkenyl polyether, said percentages being based upon the weights of unpolymerized repeating unit and cross-linking agent, respectively with (2) from about 0.1 to about 99. percent of alginic acid or a salt thereof, said interaction being performed in the presence of an active agent selected from the group consisting of medicinal agents and cosmetic agents, said interaction being at a pH from about 3 to about 10, the calcium polycarbophil being originally present, prior to said interaction, in the form of the calcium salt, having a calcium, and wherein the ratio of said reaction complex to said active agent is about 200,000:1 to about 1:100'.
A method of controlled release treatment comprising the steps of:
Dependencies are inferred from the claim text.